Ad is loading...
PACB
Price
$1.84
Change
+$0.08 (+4.52%)
Updated
Nov 22, 03:32 PM (EDT)
83 days until earnings call
RVTY
Price
$112.53
Change
+$1.42 (+1.28%)
Updated
Nov 22, 03:36 PM (EDT)
68 days until earnings call
Ad is loading...

PACB vs RVTY

Header iconPACB vs RVTY Comparison
Open Charts PACB vs RVTYBanner chart's image
Pacific Biosciences of California
Price$1.84
Change+$0.08 (+4.52%)
Volume$4.1K
CapitalizationN/A
Revvity
Price$112.53
Change+$1.42 (+1.28%)
Volume$100
CapitalizationN/A
PACB vs RVTY Comparison Chart
Loading...
PACB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
PACB vs. RVTY commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACB is a Hold and RVTY is a Sell.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (PACB: $1.77 vs. RVTY: $111.11)
Brand notoriety: PACB and RVTY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PACB: 82% vs. RVTY: 162%
Market capitalization -- PACB: $976.68M vs. RVTY: $12.76B
PACB [@Medical Specialties] is valued at $976.68M. RVTY’s [@Medical Specialties] market capitalization is $12.76B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PACB’s FA Score shows that 0 FA rating(s) are green whileRVTY’s FA Score has 0 green FA rating(s).

  • PACB’s FA Score: 0 green, 5 red.
  • RVTY’s FA Score: 0 green, 5 red.
According to our system of comparison, both PACB and RVTY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PACB’s TA Score shows that 4 TA indicator(s) are bullish while RVTY’s TA Score has 4 bullish TA indicator(s).

  • PACB’s TA Score: 4 bullish, 5 bearish.
  • RVTY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PACB is a better buy in the short-term than RVTY.

Price Growth

PACB (@Medical Specialties) experienced а -4.58% price change this week, while RVTY (@Medical Specialties) price change was -4.26% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.14%. For the same industry, the average monthly price growth was +0.91%, and the average quarterly price growth was -2.33%.

Reported Earning Dates

PACB is expected to report earnings on Feb 13, 2025.

RVTY is expected to report earnings on Jan 29, 2025.

Industries' Descriptions

@Medical Specialties (+3.14% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVTY($12.8B) has a higher market cap than PACB($977M). RVTY YTD gains are higher at: 1.910 vs. PACB (-81.957). RVTY has higher annual earnings (EBITDA): 714M vs. PACB (-277.28M). RVTY has more cash in the bank: 1.6B vs. PACB (631M). PACB has less debt than RVTY: PACB (934M) vs RVTY (4.07B). RVTY has higher revenues than PACB: RVTY (2.75B) vs PACB (201M).
PACBRVTYPACB / RVTY
Capitalization977M12.8B8%
EBITDA-277.28M714M-39%
Gain YTD-81.9571.910-4,292%
P/E RatioN/A71.72-
Revenue201M2.75B7%
Total Cash631M1.6B39%
Total Debt934M4.07B23%
FUNDAMENTALS RATINGS
PACB vs RVTY: Fundamental Ratings
PACB
RVTY
OUTLOOK RATING
1..100
7062
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10076
SMR RATING
1..100
9885
PRICE GROWTH RATING
1..100
6257
P/E GROWTH RATING
1..100
8386
SEASONALITY SCORE
1..100
5040

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RVTY's Valuation (77) in the Medical Specialties industry is in the same range as PACB (99) in the Biotechnology industry. This means that RVTY’s stock grew similarly to PACB’s over the last 12 months.

RVTY's Profit vs Risk Rating (76) in the Medical Specialties industry is in the same range as PACB (100) in the Biotechnology industry. This means that RVTY’s stock grew similarly to PACB’s over the last 12 months.

RVTY's SMR Rating (85) in the Medical Specialties industry is in the same range as PACB (98) in the Biotechnology industry. This means that RVTY’s stock grew similarly to PACB’s over the last 12 months.

RVTY's Price Growth Rating (57) in the Medical Specialties industry is in the same range as PACB (62) in the Biotechnology industry. This means that RVTY’s stock grew similarly to PACB’s over the last 12 months.

PACB's P/E Growth Rating (83) in the Biotechnology industry is in the same range as RVTY (86) in the Medical Specialties industry. This means that PACB’s stock grew similarly to RVTY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PACBRVTY
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 17 days ago
84%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
63%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
56%
View a ticker or compare two or three
Ad is loading...
PACB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTXCX46.730.90
+1.96%
FullerThaler Behavioral Sm-Cp Gr C
IOEZX17.160.22
+1.30%
ICON Equity Income Institutional
HLMNX26.620.19
+0.72%
Harding Loevner International Eq Inv
WEMMX16.25N/A
N/A
TETON Westwood Mighty Mites AAA
TINFX24.15-1.80
-6.94%
Thornburg International Growth R5

PACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PACB has been loosely correlated with MASI. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if PACB jumps, then MASI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PACB
1D Price
Change %
PACB100%
+2.91%
MASI - PACB
58%
Loosely correlated
+2.53%
AZTA - PACB
47%
Loosely correlated
+1.97%
MASS - PACB
45%
Loosely correlated
+7.03%
RVTY - PACB
44%
Loosely correlated
-0.21%
TWST - PACB
42%
Loosely correlated
+1.34%
More

RVTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVTY has been loosely correlated with TMO. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if RVTY jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVTY
1D Price
Change %
RVTY100%
-0.21%
TMO - RVTY
62%
Loosely correlated
+0.64%
SYK - RVTY
60%
Loosely correlated
+1.16%
A - RVTY
59%
Loosely correlated
+2.71%
BIO - RVTY
56%
Loosely correlated
+0.58%
MTD - RVTY
56%
Loosely correlated
+2.56%
More